Anaemia in neoplastic disease Clinical Trials

3 clinical trials for Anaemia in neoplastic disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Effects of ACE 536 for the Treatment of Anemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Previously Enrolled in Study A536-03 — RECRUITING
• A Phase 2, Open Label, Ascending Dose Study of ACE-536 for the Treatment of Anemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) — RECRUITING
• Phase IIa Study to Characterize the Effects of the Spiegelmer® NOX H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or Lymphoma — RECRUITING

Refine this search